Similarly, Harper et al. showed that adenoviral gene delivery of BMPR2 inhibited MCT-induced PAH by reducing RV hypertrophy, RVSP, and mean PAP [38]. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.